spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.


Figure 6


Fig. 6. The role of ERK in SPC-induced expression of {alpha}-SMA and delayed phosphorylation of Smad2. (A) Serum-starved hATSCs were treated with 2 µM D-erythro-SPC or 2 ng/ml TGF-ß3 for the indicated time periods. (B) hATSCs were pretreated with 100 ng/ml PTX for 24 hours, and then exposed to 2 µM D-erythro-SPC for 10 minutes. (C) hATSCs were pretreated with 10 µM U0126 for 15 minutes, and then exposed to 2 µM D-erythro-SPC or 2 ng/ml TGF-ß3 for 4 days. (D) hATSCs were pretreated with 10 µM U0126 for 15 minutes, and then exposed to 2 µM D-erythro-SPC or 2 ng/ml TGF-ß3 for 10 minutes. The expression levels of {alpha}-SMA, actin, and ERK were determined by western blotting with anti-{alpha}-SMA, anti-actin and anti-ERK antibodies, respectively. The phosphorylation levels of ERK and Smad2 were determined by western blotting with anti-p-ERK and anti-p-Smad2 antibodies, respectively. Representative data from three independent experiments are shown.





Right arrow Return to article